BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36412122)

  • 1. 5-Hydroxyeicosatetraenoic Acid Controls Androgen Reduction in Diverse Types of Human Epithelial Cells.
    Hardaway AL; Goudarzi M; Berk M; Chung YM; Zhang R; Li J; Klein E; Sharifi N
    Endocrinology; 2022 Nov; 164(1):. PubMed ID: 36412122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride.
    Byrns MC; Mindnich R; Duan L; Penning TM
    J Steroid Biochem Mol Biol; 2012 May; 130(1-2):7-15. PubMed ID: 22265960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review.
    Karunasinghe N; Masters J; Flanagan JU; Ferguson LR
    Curr Cancer Drug Targets; 2017; 17(7):603-616. PubMed ID: 28359237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 regulates androgen synthesis in prostate cancer cells.
    Chun JY; Nadiminty N; Dutt S; Lou W; Yang JC; Kung HJ; Evans CP; Gao AC
    Clin Cancer Res; 2009 Aug; 15(15):4815-22. PubMed ID: 19638459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
    Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
    Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression.
    Xia D; Lai DV; Wu W; Webb ZD; Yang Q; Zhao L; Yu Z; Thorpe JE; Disch BC; Ihnat MA; Jayaraman M; Dhanasekaran DN; Stratton KL; Cookson MS; Fung KM; Lin HK
    J Steroid Biochem Mol Biol; 2018 Apr; 178():89-98. PubMed ID: 29155210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells.
    Rizner TL; Lin HK; Penning TM
    Chem Biol Interact; 2003 Feb; 143-144():401-9. PubMed ID: 12604227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dehydrogenase/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: Substrate and reaction specificity in the reduction of 11-keto-C
    Endo S; Morikawa Y; Kudo Y; Suenami K; Matsunaga T; Ikari A; Hara A
    J Steroid Biochem Mol Biol; 2020 May; 199():105586. PubMed ID: 31926269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells.
    Verma K; Gupta N; Zang T; Wangtrakluldee P; Srivastava SK; Penning TM; Trippier PC
    Mol Cancer Ther; 2018 Sep; 17(9):1833-1845. PubMed ID: 29891491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells.
    Colombero C; Papademetrio D; Sacca P; Mormandi E; Alvarez E; Nowicki S
    Horm Cancer; 2017 Aug; 8(4):243-256. PubMed ID: 28639228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer.
    Hamid AR; Pfeiffer MJ; Verhaegh GW; Schaafsma E; Brandt A; Sweep FC; Sedelaar JP; Schalken JA
    Mol Med; 2013 Jan; 18(1):1449-55. PubMed ID: 23196782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a highly specific monoclonal antibody against human aldo-keto reductase AKR1C3.
    Liu J; He P; Lin L; Zhao Y; Deng W; Ding H; Li Q; Wang Z
    Steroids; 2019 Mar; 143():73-79. PubMed ID: 30639543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood mononuclear cells preferentially activate 11-oxygenated androgens.
    Schiffer L; Bossey A; Kempegowda P; Taylor AE; Akerman I; Scheel-Toellner D; Storbeck KH; Arlt W
    Eur J Endocrinol; 2021 Mar; 184(3):353-363. PubMed ID: 33444228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica nanoparticles combined with AKR1C3 siRNA inhibited the growth of castration-resistant prostate cancer by suppressing androgen synthesis in vitro and in vivo.
    Chen J; Yang Y; Xu D; Li J; Wu S; Jiang Y; Wang C; Yang Z; Zhao L
    Biochem Biophys Res Commun; 2021 Feb; 540():83-89. PubMed ID: 33450484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis.
    Xu Z; Ma T; Zhou J; Gao W; Li Y; Yu S; Wang Y; Chan FL
    Theranostics; 2020; 10(9):4201-4216. PubMed ID: 32226548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.
    Stanbrough M; Bubley GJ; Ross K; Golub TR; Rubin MA; Penning TM; Febbo PG; Balk SP
    Cancer Res; 2006 Mar; 66(5):2815-25. PubMed ID: 16510604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.
    Tian Y; Zhao L; Wang Y; Zhang H; Xu D; Zhao X; Li Y; Li J
    Asian J Androl; 2016; 18(4):607-12. PubMed ID: 26698234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors.
    Mitsiades N; Sung CC; Schultz N; Danila DC; He B; Eedunuri VK; Fleisher M; Sander C; Sawyers CL; Scher HI
    Cancer Res; 2012 Dec; 72(23):6142-52. PubMed ID: 22971343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.
    Ji Q; Chang L; VanDenBerg D; Stanczyk FZ; Stolz A
    Prostate; 2003 Mar; 54(4):275-89. PubMed ID: 12539226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
    Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
    Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.